Dyax

 

Advancing Novel Biotherapeutics Since 1995®

 

Opportunities for growth stem from our established success and valued collaborations.

SEC Filings

  
Filing Description Date Filed Sorted Ascending Size View  
4 littlechild, john w Jun 6, 2002 31.4 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Jul 2, 2002 36.1 KB View HTML View PDF View XLS Add to Briefcase
S-8 registration statement Aug 1, 2002 82.7 KB View HTML View PDF View XLS Add to Briefcase
S-8 registration statement Aug 1, 2002 43.6 KB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Aug 14, 2002 564.2 KB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Nov 14, 2002 205.6 KB View HTML View PDF View XLS Add to Briefcase
SC 13G/A amended statement of beneficial ownership Jan 29, 2003 28.0 KB View HTML View PDF View XLS Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 10, 2003 70.3 KB View HTML View PDF View XLS Add to Briefcase
SC 13G statement of beneficial ownership Feb 11, 2003 51.2 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Feb 19, 2003 44.7 KB View HTML View PDF View XLS Add to Briefcase
424B5 prospectus filed pursuant to rule 424 Mar 18, 2003 374.5 KB View HTML View PDF View XLS Add to Briefcase
8-K current report Mar 18, 2003 71.2 KB View HTML View PDF View XLS Add to Briefcase
424B5 prospectus filed pursuant to rule 424 Mar 18, 2003 369.9 KB View HTML View PDF View XLS Add to Briefcase
SC 13D general statement of beneficial ownership Mar 24, 2003 46.6 KB View HTML View PDF View XLS Add to Briefcase
10-K annual report Mar 27, 2003 933.1 KB View HTML View PDF View XLS Add to Briefcase
SC 13G statement of beneficial ownership Apr 8, 2003 35.8 KB View HTML View PDF View XLS Add to Briefcase
SC 13D/A amended general statement of beneficial ownership Apr 9, 2003 36.7 KB View HTML View PDF View XLS Add to Briefcase
DEF 14A definitive proxy statement Apr 15, 2003 265.6 KB View HTML View PDF View XLS Add to Briefcase
ARS annual report to security holders Apr 21, 2003 0.0 KB View HTML  
SC 13D general statement of beneficial ownership Apr 24, 2003 27.6 KB View HTML View PDF View XLS Add to Briefcase
Showing 41-60 of 580 Page: 1 2 3 4 5 6 7 ... 29  Previous 20 | Next 20
Add to Briefcase = add PDF file to Briefcase

Print

Print Page

 		E-mail

E-mail Page


May 23, 2013, 4:12 PM ET

Stock quote

Exchange NASDAQ (US Dollars)
Price $2.62
Change (%) 0.09 (3.56)%
See more

IR TOOL KIT

Investor Relations Contacts

Jennifer Robinson
Associate Director, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500


See All

 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?